Whole-Transcriptome Sequencing Identifies Novel IRF2BP2-CDX1 Fusion Gene Brought about by Translocation t(1;5)(q42;q32) in Mesenchymal Chondrosarcoma

• Kaja B. Nyquist ,

  * E-mail: k.b.nyquist@medisin.uio.no

  Affiliations Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Ioannis Panagopoulos,

  Affiliations Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway

  ⨯
• Jim Thorsen,

  Affiliations Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway

  ⨯
• Lisbeth Haugom,

  Affiliations Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway

  ⨯
• Ludmila Gorunova,

  Affiliations Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway

  ⨯
• Bodil Bjerkehagen,

  Affiliation Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Alexander Fosså,

  Affiliation Department of Oncology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Marianne Guriby,

  Affiliations Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway, Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Torfinn Nome,

  Affiliations Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway, Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Ragnhild A. Lothe,

  Affiliations Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway, Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Rolf I. Skotheim,

  Affiliations Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway, Department of Cancer Prevention, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway

  ⨯
• Sverre Heim,

  Affiliations Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Francesca Micci

  Affiliations Section for Cancer Cytogenetics, Institute for Medical Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway

  ⨯